1
Effect of Sodium Glucose Cotransporter Inhibitors on Non Diabetic Fatty Liver Disease Patients
Condition(s):Fatty Liver DiseaseLast Updated:January 23, 2023Not yet recruiting
Fatty Liver Nonalcoholic Nondiabetic: 23 Clinical Trials, Page 1 of 3
Hide Studies Not Open or Pending
2
ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:September 9, 2022Active, not recruiting
3
Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)
Condition(s):Liver DiseasesLast Updated:April 6, 2018Completed
4
Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:June 28, 2018Completed
5
Comparative Clinical Study Between Empagliflozin Versus Pioglitazone in Non-diabetic Patients With Non-alcoholic Steatohepatitis
Condition(s):Non Alcoholic SteatohepatitisLast Updated:November 4, 2022Not yet recruiting
6
Efficacy and Safety of Dapagliflozin in Patients With Non-alcoholic Steatohepatitis
Condition(s):Non-alcoholic SteatohepatitisLast Updated:September 14, 2022Recruiting
7
Extension of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With (NAFLD)
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:October 12, 2022Active, not recruiting
8
Assessment of Nonalcoholic Fatty Liver Disease in Diabetic and Prediabetic Patients Using Noninvasive Methods.
Condition(s):Non Alcoholic Fatty LiverLast Updated:December 23, 2020Unknown status
9
Vitamin E Versus Placebo for the Treatment of Non Diabetic Patients With Nonalcoholic Steatohepatitis
Condition(s):NASH (Non-Alcoholic Steatohepatitis)Last Updated:February 15, 2022Completed
10
Effect of Empagliflozin on Liver Fat in Non-diabetic Patients
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:May 25, 2022Active, not recruiting